Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of adenoviral eye infection with Betadine and cyclosporine
2017-004614-25Phase 4Terminated
- Sponsor
- Helsinki Eye Hospital
- Start
- Dec 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of povidone-iodine and cyclosporine in adenoviral keratoconjunctivitis (EKC), adenoviral conjunctivitis and corneal fibrosis (3 arms), sponsored by Helsinki Eye Hospital. Primary endpoints: Resolution of adenoviral eye infection, Improvement of corneal scarring and 1 more. Started Dec 2017; status: terminated.
02
Drugs
povidone-iodinecyclosporine
03
Conditions
adenoviral keratoconjunctivitis (EKC)adenoviral conjunctivitiscorneal fibrosis
Beyond the preview
Go deeper on 2017-004614-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004614-25.